Mieyal Paul A 4
4 · Nile Therapeutics, Inc. · Filed Jul 28, 2010
Insider Transaction Report
Form 4
Mieyal Paul A
Director
Transactions
- Award
Stock Option (Right to Buy)
2010-07-26+80,000→ 80,000 totalExercise: $0.37From: 2011-07-26Exp: 2020-07-26→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]These options have been assigned to Wexford Capital LP